diabetes
AstraZeneca launches prostate cancer app
August 7, 2012Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate
AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …
BMS unveils $165m expansion in Puerto Rico
July 17, 2012Manufacturing and Production BMS, Puerto Rico, diabetes, manufacturing
A facility operated by Bristol-Myers Squibb in Puerto Rico stands to benefit from a $165 million investment programme that will …
Boehringer collaborates for online ‘beyond pill’ plan
July 11, 2012Medical Communications Boehringer, diabetes, digital, healthrageous
Boehringer Ingelheim is collaborating with US digital health specialist Healthrageous on a scheme to help type II diabetes sufferers manage …
Janssen buys into regenerative diabetes portfolio
July 11, 2012Research and Development, Sales and Marketing CureBeta, Evotec, Janssen, diabetes
Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …
R&D, East & West: Lilly invests in its global research network
July 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly
Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …
Positive data for Sanofi’s diabetes drug
June 13, 2012Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes
Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …
BMS invests $15 million in Asian diabetes programme
June 11, 2012Sales and Marketing Asia, BMS, China, India, Onglyza, diabetes
Bristol-Myers Squibb has invested $15 million into its ‘Together on Diabetes’ campaign in India and China. Together on Diabetes is …
AstraZeneca diabetes drug recommended in Europe
April 23, 2012Sales and Marketing AstraZeneca, CHMP, FDA, Merck, WHO, diabetes
AstraZeneca and Bristol-Myers Squibb’s new type II diabetes treatment Forxiga has received a positive opinion by European regulators. The European …
Diabetes UK launches new peer support service
April 16, 2012Diabetes UK, diabetes, peer support
Diabetes UK has launched a new support service that puts people with diabetes in touch with others who have the …
Januvia gains renal impairment licence in UK
April 13, 2012Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment
Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
Victoza superiority to Januvia made official by FDA
April 10, 2012Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes
Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …
Roche sponsors Twitter-based diabetes community
April 5, 2012Medical Communications Ignite Health, Roche, Twitter, diabetes
Roche is to sponsor a Twitter-based site devoted talk about diabetes, furthering its close links with online commentators. ‘Diabetes Nest’ …
GSK’s diabetes drug misses goal
April 4, 2012Research and Development, Sales and Marketing Bydureon, GSK, Victoza, albiglutide, diabetes
GlaxoSmithKline has insisted its new long-acting Type 2 diabetes drug albiglutide remains on course for filing following topline results from …
Amylin dismisses BMS acquisition deal
March 30, 2012Manufacturing and Production, Sales and Marketing Amylin, BMS, Bydureon, diabetes, lilly
Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …
Trajenta article lands Boehringer in hot water
March 19, 2012Sales and Marketing ABPI Code, PMCPA, Trajenta, breach, diabetes
Boehringer Ingelheim has been publicly reprimanded for multiple breaches of the ABPI Code of Practice. In total the manufacturer fell …
Latest content
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner
